iktos
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,122 115 7,472Activities
Technologies
Entity types
Location
65 Rue de Prony, 75017 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 84
SIREN
823189279Engaged corporates
37
10 27Added in Motherbase
6 years, 1 month ago
deeptech Value proposition
Artificial intelligence for new drug design
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization.
Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity.
Please visit our webpage to know more about our products and offerings
https://iktos.ai/products/
artificial intelligence, medicinal chemistry, chemoinformatics, machine learning, deep learning, molecular modeling, CADD, MPO, de novo drug design, virtual screening, drug design, inverse-QSAR, QSAR, and lead optimizationOriginal language
Artificial intelligence for new drug design
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization.
Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity.
Please visit our webpage to know more about our products and offerings
https://iktos.ai/products/
Iktos
https://iktos.ai/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 13 Nov 2024 | | |
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Nov 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 13 Nov 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 8 Nov 2024 | | |
 Teijin Limited Chemistry | Teijin Limited Chemistry | Other 3 Aug 2024 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 19 Oct 2024 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 1 May 2024 | | |
 McKinsey & Company Consulting, Business Consulting and Services | McKinsey & Company Consulting, Business Consulting and Services | Other 24 Apr 2024 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 22 Sep 2024 | | |
 Elsevier Publishing, IT Services and IT Consulting | Elsevier Publishing, IT Services and IT Consulting | Other 19 Oct 2024 | | |